European Association of Urology Guidelines on Male Urinary Incontinence

Context: Urinary incontinence (UI) is a common condition in elderly men causing a sev-ere worsening of quality of life, and a significant cost for both patients and health sys-tems. Objective: To report a practical, evidence-based, guideline on definitions, pathophysiol-ogy, diagnostic workup, and treatment options for men with different forms of UI. Evidence acquisition: A comprehensive literature search, limited to studies representing high levels of evidence and published in the English language, was performed. Databases searched included Medline, EMBASE, and the Cochrane Libraries. A level of evidence and a grade of recommendation were assigned. Evidence synthesis: UI can be classified into stress urinary incontinence (SUI), urge uri-nary incontinence (UUI), and mixed urinary incontinence. A detailed description of the pathophysiology and diagnostic workup has been reported. Simple clinical interven-tions, behavioural and physical modifications, and pharmacological treatments comprise the initial management for all kinds of UI. Surgery for SUI includes bulking agents, male sling, and compression devices. Surgery for UUI includes bladder wall injection of botu-linum toxin A, sacral nerve stimulation, and cystoplasty/urinary diversion. Conclusions: This 2022 European Association of Urology guideline summary provides updated information on definition, pathophysiology, diagnosis, and treatment of male UI. Patient summary: Male urinary incontinence comprises a broad subject area, much of which has been covered for the first time in the literature in a single manuscript. The European Association of Urology Non-neurogenic Male Lower Urinary Tract Symptoms Guideline Panel has released this new guidance, with the aim to provide updated information for urologists to be able to follow diagnostic and therapeutic indications for optimising patient care. (c) 2022 Published by Elsevier B.V. on behalf of European Association of Urology.